Tarbox Family Office’s Immunogen Inc IMGN Stock Holding History

Tarbox Family Office’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-413	Closed	-$1K	–	1195
2019 Q3	$1K	Sell	413 -305	-42%	-$810	﹤0.01%	1042
2019 Q2	$2K	Buy	+718	New	+$1.7K	﹤0.01%	834

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tarbox Family Office's IMGN Position: Q4 2019 in Review

Tarbox Family Office sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 413 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in IMGN in Q2 2019 and held it in 2 quarters. The position peaked at $2K in Q2 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

Tarbox Family Office reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
Tarbox Family Office sold 413 Immunogen Inc shares in Q4 2019, an estimated $1K.
Tarbox Family Office first reported a position in Immunogen Inc in Q2 2019 and held it in 2 quarters.
Tarbox Family Office's Immunogen Inc position peaked at $2K in Q2 2019.
191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Tarbox Family Office's 13F filing for Q4 2019, filed 31 Jan 2020.